Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Regadenoson R-T Perfusion Imaging Trial

This study has been completed.
Mayo Clinic
Astellas Pharma Inc
Information provided by (Responsible Party):
Thomas R. Porter, MD, University of Nebraska Identifier:
First received: February 3, 2009
Last updated: July 19, 2012
Last verified: July 2012
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: December 2011
  Primary Completion Date: March 2011 (Final data collection date for primary outcome measure)